We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Show more
CAHmelia-204 Study of 200mg Once-Daily (QD) Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Did Not Achieve Primary Endpoint of Glucocorticoid (GC) Reduction Dose-Ranging Data from...
Topline Data from CAHmelia-204 Study of Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Anticipated in December 2024 Topline Data from CAHptain-205 Study of Tildacerfont in Adult and...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0037 | 0.925 | 0.4 | 0.4111 | 0.365 | 437102 | 0.38543088 | CS |
4 | -0.1389 | -25.5989679322 | 0.5426 | 0.574 | 0.365 | 939801 | 0.45712006 | CS |
12 | -0.0479 | -10.6067316209 | 0.4516 | 0.608 | 0.365 | 553465 | 0.48721296 | CS |
26 | -0.1662 | -29.1630110546 | 0.5699 | 0.608 | 0.365 | 479712 | 0.48695043 | CS |
52 | -1.7463 | -81.223255814 | 2.15 | 5.95 | 0.365 | 681631 | 1.12353921 | CS |
156 | -3.2463 | -88.9397260274 | 3.65 | 5.95 | 0.365 | 523328 | 2.14359437 | CS |
260 | -16.5963 | -97.6252941176 | 17 | 35.6 | 0.365 | 548726 | 3.29160793 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions